Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Liporeduct Forte

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 57456-45-8, 2-(4-chlorophenoxy)-2-methylpropanoic acid;[2,3,4,5,6-pentakis(pyridine-3-carbonyloxy)cyclohexyl] pyridine-3-carboxylate, Clofibrate - inositol hexanicotinate mixture, Inositol hexanicotinate - clofibrate mixture, Clofibrate mixture with inositol hexanicotinate, Clofibrate - inositol nicotinate
    Molecular Formula
    C52H41ClN6O15
    Molecular Weight
    1025.4  g/mol
    InChI Key
    GMZMSRVZQKDYFL-UHFFFAOYSA-N
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    2-(4-chlorophenoxy)-2-methylpropanoic acid;[2,3,4,5,6-pentakis(pyridine-3-carbonyloxy)cyclohexyl] pyridine-3-carboxylate
    2.1.2 InChI
    InChI=1S/C42H30N6O12.C10H11ClO3/c49-37(25-7-1-13-43-19-25)55-31-32(56-38(50)26-8-2-14-44-20-26)34(58-40(52)28-10-4-16-46-22-28)36(60-42(54)30-12-6-18-48-24-30)35(59-41(53)29-11-5-17-47-23-29)33(31)57-39(51)27-9-3-15-45-21-27;1-10(2,9(12)13)14-8-5-3-7(11)4-6-8/h1-24,31-36H;3-6H,1-2H3,(H,12,13)
    2.1.3 InChI Key
    GMZMSRVZQKDYFL-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl.C1=CC(=CN=C1)C(=O)OC2C(C(C(C(C2OC(=O)C3=CN=CC=C3)OC(=O)C4=CN=CC=C4)OC(=O)C5=CN=CC=C5)OC(=O)C6=CN=CC=C6)OC(=O)C7=CN=CC=C7
    2.2 Synonyms
    2.2.1 MeSH Synonyms

    1. Clofibrate - Inositol Nicotinate

    2. Clofibrate, Inositol Nicotinate Drug Combination

    3. Liporeduct

    2.2.2 Depositor-Supplied Synonyms

    1. 57456-45-8

    2. 2-(4-chlorophenoxy)-2-methylpropanoic Acid;[2,3,4,5,6-pentakis(pyridine-3-carbonyloxy)cyclohexyl] Pyridine-3-carboxylate

    3. Clofibrate - Inositol Hexanicotinate Mixture

    4. Inositol Hexanicotinate - Clofibrate Mixture

    5. Clofibrate Mixture With Inositol Hexanicotinate

    6. Clofibrate - Inositol Nicotinate

    7. Clofibrate, Inositol Nicotinate Drug Combination

    8. Myo-inositol, Hexa-3-pyridinecarboxylate, Mixt. With 2-(4-chlorophenoxy)-2-methylpropanoic Acid

    2.3 Create Date
    2007-01-09
    3 Chemical and Physical Properties
    Molecular Weight 1025.4 g/mol
    Molecular Formula C52H41ClN6O15
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count21
    Rotatable Bond Count21
    Exact Mass1024.2318423 g/mol
    Monoisotopic Mass1024.2318423 g/mol
    Topological Polar Surface Area282 Ų
    Heavy Atom Count74
    Formal Charge0
    Complexity1420
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2